Wouter T. Zandee

1.4k total citations
38 papers, 836 citations indexed

About

Wouter T. Zandee is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Wouter T. Zandee has authored 38 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 22 papers in Epidemiology and 16 papers in Neurology. Recurrent topics in Wouter T. Zandee's work include Neuroendocrine Tumor Research Advances (22 papers), Lung Cancer Research Studies (20 papers) and Neuroblastoma Research and Treatments (15 papers). Wouter T. Zandee is often cited by papers focused on Neuroendocrine Tumor Research Advances (22 papers), Lung Cancer Research Studies (20 papers) and Neuroblastoma Research and Treatments (15 papers). Wouter T. Zandee collaborates with scholars based in Netherlands, Sweden and Italy. Wouter T. Zandee's co-authors include Wouter W. de Herder, Johannes Hofland, Richard A. Feelders, Anela Blažević, Tessa Brabander, Kimberly Kamp, Boen L.R. Kam, Jaap J.M. Teunissen, Aura D. Herrera‐Martínez and Marie‐Louise F. van Velthuysen and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Wouter T. Zandee

34 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wouter T. Zandee Netherlands	15	678	626	512	108	104	38	836
Rachel S. van Leeuwaarde Netherlands	14	425 0.6×	350 0.6×	294 0.6×	99 0.9×	61 0.6×	43	556
Séverine Martinez France	4	1.4k 2.0×	1.3k 2.0×	1.1k 2.1×	95 0.9×	70 0.7×	6	1.5k
Anouk N. van der Horst‐Schrivers Netherlands	15	484 0.7×	352 0.6×	335 0.7×	133 1.2×	82 0.8×	17	603
Aaron T. Scott United States	9	294 0.4×	272 0.4×	204 0.4×	142 1.3×	202 1.9×	13	504
Pavel Nockel United States	11	281 0.4×	205 0.3×	172 0.3×	94 0.9×	124 1.2×	17	439
Martin B. Niederle Austria	8	403 0.6×	331 0.5×	222 0.4×	140 1.3×	125 1.2×	26	535
Beth Chasen United States	11	369 0.5×	343 0.5×	261 0.5×	42 0.4×	78 0.8×	19	557
Yi‐Zarn Wang United States	16	387 0.6×	364 0.6×	278 0.5×	18 0.2×	66 0.6×	47	567
Carolina R C Pieterman Netherlands	21	1.0k 1.5×	704 1.1×	647 1.3×	226 2.1×	125 1.2×	43	1.1k
Dimitrios Papadogias Greece	8	210 0.3×	151 0.2×	162 0.3×	191 1.8×	149 1.4×	12	446

Countries citing papers authored by Wouter T. Zandee

Since Specialization

Citations

This map shows the geographic impact of Wouter T. Zandee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter T. Zandee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter T. Zandee more than expected).

Fields of papers citing papers by Wouter T. Zandee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter T. Zandee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter T. Zandee. The network helps show where Wouter T. Zandee may publish in the future.

Co-authorship network of co-authors of Wouter T. Zandee

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter T. Zandee. A scholar is included among the top collaborators of Wouter T. Zandee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter T. Zandee. Wouter T. Zandee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verbeek, Hans H G, Liesbeth Jansen, Adrienne H. Brouwers, et al.. (2025). Toxicity and Quality of Life After Locoregional Radiotherapy in Patients With Thyroid Cancer. Head & Neck. 47(6). 1653–1664.

Hemel, Bettien M. van, Bea Rutgers, Wouter T. Zandee, et al.. (2025). Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer. Cancers. 17(5). 737–737.

Post, Adrian, et al.. (2025). Hypothyroidism consequent to thyroidectomy is associated with elevated remnant lipoproteins and cholesterol enrichment of triglyceride-rich lipoproteins: an observational study. Lipids in Health and Disease. 24(1). 142–142.

Zandee, Wouter T., Liesbeth Jansen, Bettien M. van Hemel, et al.. (2024). Trends in the Incidence, Organization of Care, and Surgical Treatment of Medullary Thyroid Cancer: A Population-Based Study. Thyroid. 35(1). 87–96. 1 indexed citations

Links, Thera P., Renske Altena, Tessa M. van Ginhoven, et al.. (2024). Does a Restrictive Diagnostic Work‐up for Thyroid Nodules Lead to a Different Papillary Thyroid Cancer Patient Population? A Comparison Between Dutch and U.S. T1‐T3 Patient Population. World Journal of Surgery. 49(4). 985–996. 1 indexed citations

Mols, Floortje, Dounya Schoormans, Romana T. Netea‐Maier, et al.. (2023). Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the design of the WaTCh study. Thyroid Research. 16(1). 23–23. 4 indexed citations

Noltes, Milou E., Schelto Kruijff, Auke P.A. Appelman, et al.. (2023). Head-to-head comparison of [11C]methionine PET, [11C]choline PET, and 4-dimensional CT as second-line scans for detection of parathyroid adenomas in primary hyperparathyroidism. European Journal of Nuclear Medicine and Molecular Imaging. 51(4). 1050–1059. 7 indexed citations

Pieterman, Carolina R C, Frank J. Wessels, Annenienke C. van de Ven, et al.. (2022). Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice. Frontiers in Endocrinology. 13. 926491–926491. 3 indexed citations

Dreijerink, Koen M.A., Rachel H. Giles, Anouk N.A. van der Horst‐Schrivers, et al.. (2022). Multidisciplinary integrated care pathway for von Hippel–Lindau disease. Cancer. 128(15). 2871–2879. 6 indexed citations

10.

Brouwers, Adrienne H., Derk Jan A. de Groot, Johannes Hofland, et al.. (2022). Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy. SHILAP Revista de lepidopterología. 6(1). 12–12. 3 indexed citations

11.

Noltes, Milou E., Laura Kracht, Inês F. Antunes, et al.. (2022). Patient-derived parathyroid organoids as a tracer and drug-screening application model. Stem Cell Reports. 17(11). 2518–2530. 11 indexed citations

12.

Zandee, Wouter T., Tessa Brabander, Anela Blažević, et al.. (2021). Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome. The Journal of Clinical Endocrinology & Metabolism. 106(9). e3665–e3672. 40 indexed citations

13.

Pieterman, Carolina R C, Olaf M. Dekkers, Wouter W. de Herder, et al.. (2021). Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group. The Journal of Clinical Endocrinology & Metabolism. 106(12). 3515–3525. 9 indexed citations

14.

Zandee, Wouter T., Claire C. J. Dekkers, Anouk N.A. van der Horst‐Schrivers, et al.. (2021). The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma. Frontiers in Endocrinology. 12. 655676–655676. 3 indexed citations

15.

Noltes, Milou E., Schelto Kruijff, Liesbeth Jansen, et al.. (2021). A retrospective analysis of the diagnostic performance of 11C-choline PET/CT for detection of hyperfunctioning parathyroid glands after prior negative or discordant imaging in primary hyperparathyroidism. EJNMMI Research. 11(1). 32–32. 12 indexed citations

16.

Merola, Elettra, Wouter T. Zandee, Louis de Mestier, et al.. (2020). Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference?. Neuroendocrinology. 111(1-2). 170–177. 9 indexed citations

17.

Hofland, Johannes, Wouter T. Zandee, & Wouter W. de Herder. (2018). Role of biomarker tests for diagnosis of neuroendocrine tumours. Nature Reviews Endocrinology. 14(11). 656–669. 81 indexed citations

18.

Blažević, Anela, Wouter T. Zandee, Gaston J H Franssen, et al.. (2017). Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours. Endocrine Related Cancer. 25(3). 245–254. 43 indexed citations

19.

Zandee, Wouter T., et al.. (2017). Effect of hormone secretory syndromes on neuroendocrine tumor prognosis. Endocrine Related Cancer. 24(7). R261–R274. 43 indexed citations

20.

Zandee, Wouter T., et al.. (2017). Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework. Annals of Oncology. 28(12). 3022–3027. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact